VEDERE BIO LL
Vedere is developing cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss from Inherited Retinal Degenerations (IRDs), as well as other causes of both genetic and non-genetic vision loss. While the vast majority of ocular gene therapies only limit the rate of inevitable vision loss, we aim to restore lost vision regardless of a patient’s underlying genetics or their stage of disease.
VEDERE BIO LL
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-06-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vederebio.com
Total Employee:
11+
Status:
Active
Contact:
(857) 201-2700
Email Addresses:
[email protected]
Total Funding:
98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Adaptilens
Adaptilens develop an accommodating intraocular lens.
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Da Zen Theranostics
Da Zen Theranostics develop a product that can target cancer cells, function as a contrast agent to improve the visibility of cancer cells.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Expressable
Expressable is an online speech therapy practice for those with a communication disorder.
Eyevance Pharmaceuticals
Eyevance is a provider of ophthalmic products and therapies intended to address unmet medical needs.
Impress
Impress is a developer of orthodontic technology that offers invisible aligners.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
ReNetX Bio
ReNetX Bio is a technology platform help to restore function in patients who are suffering from spinal cord injuries, stroke and glaucoma.
Solarea Bio
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Current Employees Featured
Founder
Investors List
Octagon Capital Advisors
Octagon Capital Advisors investment in Series A - Vedere Bio ll
Retinal Degeneration Fund
Retinal Degeneration Fund investment in Series A - Vedere Bio ll
Casdin Capital
Casdin Capital investment in Series A - Vedere Bio ll
Atlas Venture
Atlas Venture investment in Series A - Vedere Bio ll
Samsara BioCapital
Samsara BioCapital investment in Series A - Vedere Bio ll
Mission BioCapital
Mission BioCapital investment in Series A - Vedere Bio ll
Foundation Fighting Blindness
Foundation Fighting Blindness investment in Series A - Vedere Bio ll
Atlas Venture
Atlas Venture investment in Series A - Vedere Bio ll
Mission BioCapital
Mission BioCapital investment in Series A - Vedere Bio ll
Official Site Inspections
http://www.vederebio.com Semrush global rank: 7.85 M Semrush visits lastest month: 427
- Host name: 104.21.39.41
- IP address: 104.21.39.41
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
